Stockholders’ Equity (Details) - Schedule of warrants activity - Warrants [Member] |
3 Months Ended |
---|---|
Mar. 31, 2023
$ / shares
shares
| |
Stockholders’ Equity (Details) - Schedule of warrants activity [Line Items] |  |
Number of Shares Under Warrant, beginning balance | shares | 1,901,802 |
Weighted Average Exercise Price, beginning balance | $ / shares | $ 7.63 |
Weighted Average Remaining Contractual Life, beginning balance | 7 years 5 months 19 days |
Number of Shares Under Warrant, Issued | shares | 586,440 |
Weighted Average Exercise Price, Issued | $ / shares | $ 9.95 |
Weighted Average Remaining Contractual Life, Issued | 1 year 21 days |
Number of Shares Under Warrant, Expired | shares | (122,150) |
Weighted Average Exercise Price, Expired | $ / shares | $ 2.57 |
Number of Shares Under Warrant, ending balance | shares | 2,366,092 |
Weighted Average Exercise Price, ending balance | $ / shares | $ 7.96 |
Weighted Average Remaining Contractual Life, ending balance | 6 years 10 days |
X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock warrant plan. No definition available.
|
X | ||||||||||
- Definition Weighted average price at which grantees could have acquired the underlying shares with respect to stock warrant of the plan that expired. No definition available.
|
X | ||||||||||
- Definition Weighted Average Exercise Price, Issued. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Weighted Average Remaining Contractual Life, beginning balance. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|